Insider trades
Versant Venture Capital VI, 10% Owner of Lenz Therapeutics LENZ, has filed 0 purchases and 52 sales on the open market. The latest trade was on 25/09/30.
Versant Venture Capital VI
10% Owner
- Company
- Lenz Therapeutics LENZ
- First filing
- 23/01/04
- Trades
- 88 trades
- Buys / sales
- 0 / 52
- 12-month net buying
- No record
- Last trade
- 25/09/30
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 25/09/30 | 25/10/02 | 224,974 sh6 trades | $46.01avg. | $10,352,070.98 | No record | |
| Open-market sale | 25/09/19 | 25/09/23 | 2,903,403 sh2 trades | $1.40avg. | $4,064,764.2 | No record | |
| Open-market sale | 25/09/18 | 25/09/22 | 135,304 sh6 trades | $42.23avg. | $5,714,064.91 | No record | |
| Open-market sale | 25/09/16–25/09/18 | 25/09/18 | 1,684,434 sh6 trades | $1.48avg. | $2,500,061.56 | No record | |
| Open-market sale | 25/08/22–25/08/26 | 25/08/26 | 188,094 sh12 trades | $39.47avg. | $7,423,963.67 | No record | |
| Open-market sale | 25/08/15–25/08/18 | 25/08/19 | 260,713 sh4 trades | $39.34avg. | $10,255,193.28 | No record | |
| Open-market sale | 25/07/10 | 25/07/14 | 191,376 sh | $34.00 | $6,506,784 | −10.8% | |
| Open-market sale | 25/06/27 | 25/07/01 | 200,000 sh | $30.47 | $6,094,000 | −10.2% | |
| Open-market sale | 25/06/18–25/06/20 | 25/06/20 | 334,801 sh3 trades | $30.19avg. | $10,107,817.95 | No record | |
| Open-market sale | 25/06/10 | 25/06/12 | 350,000 sh | $29.00 | $10,150,000 | −21.9% | |
| Open-market sale | 24/10/28–24/10/29 | 24/10/30 | 157,895 sh3 trades | $9.44avg. | $1,491,028.8 | −9.1% | |
| Open-market sale | 24/09/20 | 24/09/24 | 1,132,566 sh | $6.53 | $7,395,655.98 | −18.2% | |
| Open-market sale | 24/09/11–24/09/13 | 24/09/13 | 567,213 sh3 trades | $6.00avg. | $3,404,761.04 | −8.3% | |
| Open-market sale | 24/08/28 | 24/08/30 | 221,600 sh | $6.32 | $1,400,512 | −5.6% | |
| Open-market sale | 24/08/08–24/08/12 | 24/08/12 | 787,999 sh2 trades | $1.23avg. | $966,798.9 | −79.0% |